Mufiza Farid‐Kapadia

1.5k total citations
11 papers, 226 citations indexed

About

Mufiza Farid‐Kapadia is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Neurology. According to data from OpenAlex, Mufiza Farid‐Kapadia has authored 11 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Neurology. Recurrent topics in Mufiza Farid‐Kapadia's work include Meta-analysis and systematic reviews (3 papers), Neuroblastoma Research and Treatments (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Mufiza Farid‐Kapadia is often cited by papers focused on Meta-analysis and systematic reviews (3 papers), Neuroblastoma Research and Treatments (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Mufiza Farid‐Kapadia collaborates with scholars based in Canada, United States and United Kingdom. Mufiza Farid‐Kapadia's co-authors include Katherine E. Hutchinson, Jean Michon, Francis Donaldson, C. Michel Zwaan, Gianluca Rossato, Minlei Liao, Tanya Trippett, Birgit Geoerger, Nadège Corradini and Michela Casanova and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Journal of Clinical Epidemiology.

In The Last Decade

Mufiza Farid‐Kapadia

10 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mufiza Farid‐Kapadia Canada 7 95 49 44 39 38 11 226
Yuichi Kobayashi Japan 10 36 0.4× 21 0.4× 12 0.3× 33 0.8× 38 1.0× 36 324
Anita J. Kumar United States 11 95 1.0× 29 0.6× 30 0.7× 19 0.5× 24 0.6× 37 245
Yi‐Bin Chen United States 9 172 1.8× 30 0.6× 58 1.3× 32 0.8× 34 0.9× 12 308
Giacomo Loseto Italy 11 158 1.7× 33 0.7× 29 0.7× 30 0.8× 47 1.2× 24 343
Anthony Audino United States 10 78 0.8× 54 1.1× 14 0.3× 29 0.7× 50 1.3× 33 257
Osman Türkmen Türkiye 14 62 0.7× 57 1.2× 12 0.3× 26 0.7× 34 0.9× 65 484
Teresa de Rojas Spain 10 53 0.6× 29 0.6× 46 1.0× 6 0.2× 47 1.2× 36 286
Megan Dunne United States 8 200 2.1× 110 2.2× 8 0.2× 19 0.5× 65 1.7× 18 318
Hans‐Jürgen Hurtz Germany 4 109 1.1× 27 0.6× 27 0.6× 25 0.6× 21 0.6× 5 272
Luis Alberto More United States 8 80 0.8× 42 0.9× 42 1.0× 8 0.2× 52 1.4× 10 301

Countries citing papers authored by Mufiza Farid‐Kapadia

Since Specialization
Citations

This map shows the geographic impact of Mufiza Farid‐Kapadia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mufiza Farid‐Kapadia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mufiza Farid‐Kapadia more than expected).

Fields of papers citing papers by Mufiza Farid‐Kapadia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mufiza Farid‐Kapadia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mufiza Farid‐Kapadia. The network helps show where Mufiza Farid‐Kapadia may publish in the future.

Co-authorship network of co-authors of Mufiza Farid‐Kapadia

This figure shows the co-authorship network connecting the top 25 collaborators of Mufiza Farid‐Kapadia. A scholar is included among the top collaborators of Mufiza Farid‐Kapadia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mufiza Farid‐Kapadia. Mufiza Farid‐Kapadia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Uguen, Marianne, Magalie Hilton, Mufiza Farid‐Kapadia, et al.. (2023). Advancing drug development in pediatric oncology, a focus on cancer biology and targeted therapies: iMATRIX platform. Journal of Biopharmaceutical Statistics. 33(6). 800–811. 1 indexed citations
3.
Geoerger, Birgit, C. Michel Zwaan, Lynley V. Marshall, et al.. (2019). Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study. The Lancet Oncology. 21(1). 134–144. 105 indexed citations
4.
Peirson, Leslea, Mufiza Farid‐Kapadia, Shamara Baidoobonso, et al.. (2019). Breast cancer risk and breast screening for trans people: an integration of 3 systematic reviews. CMAJ Open. 7(3). E598–E609. 13 indexed citations
5.
Robinson, Giles, Ami V. Desai, Karen Gauvain, et al.. (2019). PDCT-13. ENTRECTINIB IN CHILDREN AND ADOLESCENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING PRIMARY CNS TUMORS. Neuro-Oncology. 21(Supplement_6). vi186–vi186. 1 indexed citations
6.
Farid‐Kapadia, Mufiza, Nancy J. Butcher, Alyssandra Chee-A-Tow, et al.. (2019). Core outcome set for children with neurological impairment and tube feeding. Developmental Medicine & Child Neurology. 62(2). 201–206. 8 indexed citations
7.
Butcher, Nancy J., Andrea Monsour, Emma J. Mew, et al.. (2019). Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT). Trials. 20(1). 161–161. 33 indexed citations
8.
Robinson, Giles, Amar Gajjar, Karen Gauvain, et al.. (2019). Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors.. Journal of Clinical Oncology. 37(15_suppl). 10009–10009. 41 indexed citations
9.
Farid‐Kapadia, Mufiza, Lisa Askie, Lisa Hartling, et al.. (2017). Do systematic reviews on pediatric topics need special methodological considerations?. BMC Pediatrics. 17(1). 57–57. 14 indexed citations
10.
11.
Tedesco, Dario, Mufiza Farid‐Kapadia, Martin Offringa, et al.. (2017). Comparative evidence on harms in pediatric randomized clinical trials from less developed versus more developed countries is limited. Journal of Clinical Epidemiology. 95. 63–72. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Kobayashi Breakdown of academic impact, for papers by Anita J. Kumar Breakdown of academic impact, for papers by Yi‐Bin Chen Breakdown of academic impact, for papers by Giacomo Loseto Breakdown of academic impact, for papers by Anthony Audino Breakdown of academic impact, for papers by Osman Türkmen Breakdown of academic impact, for papers by Teresa de Rojas Breakdown of academic impact, for papers by Megan Dunne Breakdown of academic impact, for papers by Hans‐Jürgen Hurtz Breakdown of academic impact, for papers by Luis Alberto More
Rankless by CCL
2026